// STATE LEGISLATION TRACKER

Minnesota SF 2971: Combative sports regulations modification

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: In committee

State: Minnesota
Bill: SF 2971
Filed: 2023-03-16
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Minnesota SF2971 is mainly a combative sports regulation bill, not a health care or pharmacy bill. It appears to affect peptide users only if they are licensed combat-sport participants, because the bill text includes anti-doping rules covering peptide hormones, growth factors, related substances, and mimetics.

Key Points

No clear impact on ordinary peptide prescribing or patient access
No changes found for 503A/503B compounding rules
No telehealth, NP, or naturopathic scope expansion found
Combat-sport participants could face testing for banned peptide-related substances
The bill does not appear to change controlled-substance prescribing or PDMP rules

What to Watch For

Concern Combat-sport athletes using peptide hormones or growth-factor products may face testing, discipline, or disqualification.

Note This is sports-regulation policy, not a general peptide access or clinician-scope bill.

Note Watch companion or omnibus bills, because this file points readers to SF3035 rather than standalone passage.

Where the Bill Stands

SF2971 was introduced and referred to the Senate State and Local Government and Veterans Committee on March 16, 2023, with a final note to see SF3035.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws